These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17576176)

  • 1. Management outcomes of patients with type 2 diabetes: targeting the 10-year absolute risk of coronary heart disease.
    Yong TY; Phillipov G; Phillips PJ
    Med J Aust; 2007 Jun; 186(12):622-4. PubMed ID: 17576176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of risk factors for cardiovascular diseases among Saudi diabetic patients attending primary health care service.
    Ahmed AA; Alsharief E; Alsharief A
    Diabetes Metab Syndr; 2013; 7(3):133-7. PubMed ID: 23953177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender disparities in diabetes and coronary heart disease medication among patients with type 2 diabetes: results from the DIANA study.
    Krämer HU; Raum E; Rüter G; Schöttker B; Rothenbacher D; Rosemann T; Szecsenyi J; Brenner H
    Cardiovasc Diabetol; 2012 Jul; 11():88. PubMed ID: 22838970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the EUROASPIRE III cross-sectional study.
    Gyberg V; Kotseva K; Dallongeville J; Backer GD; Mellbin L; Rydén L; Wood D; Bacquer DD;
    Eur J Prev Cardiol; 2015 Jun; 22(6):753-61. PubMed ID: 24691153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycaemic control and cardiovascular risk factor management in patients with diabetes with and without coronary artery disease: insights from the diabetes mellitus status in Canada survey.
    Grenier J; Leiter LA; Langer A; Goldin L; Teoh H; Connelly KA; Cheng AYY; Tan MK; Fitchett D; McGuire DK; Goodman SG; Yan AT
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):277-284. PubMed ID: 29474711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time trends in absolute and modifiable coronary heart disease risk in patients with Type 2 diabetes in the Swedish National Diabetes Register (NDR) 2003-2008.
    Fhärm E; Cederholm J; Eliasson B; Gudbjörnsdottir S; Rolandsson O
    Diabet Med; 2012 Feb; 29(2):198-206. PubMed ID: 21883434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recalculation of cardiovascular risk score as a surrogate marker of change in clinical care of diabetes patients: the Alphabet POEM project (Practice Of Evidence-based Medicine).
    Lee JD; Morrissey JR; Patel V;
    Curr Med Res Opin; 2004 May; 20(5):765-72. PubMed ID: 15140344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary prevention therapies for coronary heart disease in patients with type 2 diabetes: an audit.
    Sharma KK; Guptha S; Gupta R
    J Assoc Physicians India; 2012 Apr; 60():28-30. PubMed ID: 23029739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary prevention of coronary heart disease? What is cost effective in the clinical practice?].
    Kübler W
    Z Kardiol; 2005; 94 Suppl 3():III/92-9. PubMed ID: 16258799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of diabetes care and coronary heart disease absolute risk in patients with type 2 diabetes mellitus in Australian general practice.
    Wan Q; Harris MF; Jayasinghe UW; Flack J; Georgiou A; Penn DL; Burns JR
    Qual Saf Health Care; 2006 Apr; 15(2):131-5. PubMed ID: 16585115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derivation and validation of a prediction score for major coronary heart disease events in a U.K. type 2 diabetic population.
    Donnan PT; Donnelly L; New JP; Morris AD
    Diabetes Care; 2006 Jun; 29(6):1231-6. PubMed ID: 16732001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge and attitude of physicians in a major teaching hospital towards atherosclerotic risk reduction therapy in patients with peripheral arterial disease.
    Al-Omran M
    Vasc Health Risk Manag; 2007; 3(6):1019-27. PubMed ID: 18200820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry.
    Khan S; Flather M; Mister R; Delahunty N; Fowkes G; Bradbury A; Stansby G
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):442-50. PubMed ID: 17196851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes Mellitus Care Provided by Nurse Practitioners vs Primary Care Physicians.
    Kuo YF; Goodwin JS; Chen NW; Lwin KK; Baillargeon J; Raji MA
    J Am Geriatr Soc; 2015 Oct; 63(10):1980-8. PubMed ID: 26480967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study.
    Leśniak W; Bała MM; Płaczkiewicz-Jankowska E; Topór-Mądry R; Jankowski M; Sieradzki J; Banasiak W;
    Cardiol J; 2015; 22(2):150-9. PubMed ID: 25299503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparity in management of diabetes and coronary heart disease risk factors by sex in DCCT/EDIC.
    Larkin ME; Backlund JY; Cleary P; Bayless M; Schaefer B; Canady J; Nathan DM;
    Diabet Med; 2010 Apr; 27(4):451-8. PubMed ID: 20536518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using a standardized follow-up program to improve coronary heart disease secondary prevention.
    Gong Y; Yang F; Hong T; Huo Y
    Anatol J Cardiol; 2016 Feb; 16(2):84-91. PubMed ID: 26467366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of 10-year coronary heart disease risk in Caribbean type 2 diabetic patients using the UKPDS risk engine.
    Ezenwaka CE; Nwagbara E; Seales D; Okali F; Hussaini S; Raja B; Jones-LeCointe A; Sell H; Avci H; Eckel J
    Int J Cardiol; 2009 Mar; 132(3):348-53. PubMed ID: 18191239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: a retrospective cohort study from a specialised diabetes centre in Denmark.
    Safai N; Carstensen B; Vestergaard H; Ridderstråle M
    BMJ Open; 2018 Mar; 8(3):e019214. PubMed ID: 29550776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
    Isles CG; Paterson JR
    QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.